ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W955. A total of 6 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,173,000 | -88.9% | 150,000 | -75.8% | 0.03% | -89.3% |
| Q4 2018 | $28,538,000 | -41.5% | 620,400 | -43.6% | 0.24% | -40.9% |
| Q3 2018 | $48,807,000 | +272.1% | 1,100,000 | +228.7% | 0.41% | +330.2% |
| Q2 2018 | $13,117,000 | +271.5% | 334,700 | +234.7% | 0.10% | +123.3% |
| Q1 2017 | $3,531,000 | – | 100,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 12,106 | $87,562,000 | 5.23% |
| Iguana Healthcare Management, LLC | 50,000 | $3,617,000 | 2.38% |
| BOOTHBAY FUND MANAGEMENT, LLC | 189 | $1,367,000 | 0.16% |
| GROUP ONE TRADING, L.P. | 37,900 | $2,741,000 | 0.03% |
| SIMPLEX TRADING, LLC | 259 | $110,000 | 0.01% |